207 related articles for article (PubMed ID: 23570181)
61. Novel drugs--miscellaneous category.
Hosmer WD; Dubinett SM; Garon EB
J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S468-9. PubMed ID: 21102242
[No Abstract] [Full Text] [Related]
62. [Patient rights act: effect on medical practice].
Dillschneider J; Theuer D; Mieth M; Büchler MW
Chirurg; 2013 Apr; 84(4):325-6. PubMed ID: 23532485
[No Abstract] [Full Text] [Related]
63. A primer on patient education and clinical trials.
Hochhauser M
Patient Care Manag; 2003 Feb; 19(2):4-6. PubMed ID: 12674081
[No Abstract] [Full Text] [Related]
64. [Legal concerns. Healing treatment, healing trial and human experiment].
Wasserburg K
Geburtshilfe Frauenheilkd; 1995 Nov; 55(11):M146-50. PubMed ID: 8707036
[No Abstract] [Full Text] [Related]
65. Literacy, comprehension, and informed consent in clinical research.
Raich PC; Plomer KD; Coyne CA
Cancer Invest; 2001; 19(4):437-45. PubMed ID: 11405182
[TBL] [Abstract][Full Text] [Related]
66. [The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials?].
Schwarz S; Frölich L; Striebel JP; Hennerici MG
Dtsch Med Wochenschr; 2007 Jan; 132(3):108-12. PubMed ID: 17219346
[No Abstract] [Full Text] [Related]
67. Informed consent in obstetric anesthesia.
Broaddus BM; Chandrasekhar S
Anesth Analg; 2011 Apr; 112(4):912-5. PubMed ID: 21430036
[TBL] [Abstract][Full Text] [Related]
68. Chemotherapy update.
Miaskowski C
Nurs Clin North Am; 1991 Jun; 26(2):331-9. PubMed ID: 2047287
[TBL] [Abstract][Full Text] [Related]
69. The Food and Drug Administration and pragmatic clinical trials of marketed medical products.
Anderson ML; Griffin J; Goldkind SF; Zeitler EP; Wing L; Al-Khatib SM; Sherman RE
Clin Trials; 2015 Oct; 12(5):511-9. PubMed ID: 26374684
[TBL] [Abstract][Full Text] [Related]
70. Multiple Dimensions of Value: Evaluative Frameworks for New Cancer Therapies.
Cheung MC; Sabharwal M; Chambers A; Han D; Sabarre KA; Chan K
J Clin Oncol; 2016 Apr; 34(12):1428-9. PubMed ID: 26884567
[No Abstract] [Full Text] [Related]
71. New joint outpatient chemotherapy administration standards.
Dreyfuss JH
CA Cancer J Clin; 2010; 60(2):66-7. PubMed ID: 20173171
[No Abstract] [Full Text] [Related]
72. [Is the physician the insurance broker for his patients?].
Wienke A; Sailer R
Laryngorhinootologie; 2013 Dec; 92(12):834-5. PubMed ID: 24285207
[No Abstract] [Full Text] [Related]
73. Jury clears cancer center of failing to tell participants of clinical-trial risks.
Blumenstyk G; Brainard J
Chron High Educ; 2004 Apr; 50(33):A33. PubMed ID: 15287145
[No Abstract] [Full Text] [Related]
74. [Patient education and consent for care].
Villeneuve P
Rev Infirm; 2002 Sep; (83):45-6. PubMed ID: 12380267
[No Abstract] [Full Text] [Related]
75. Participation of children in clinical trials: UK, European and international legal perspectives on consent.
Plomer A
Med Law Int; 2000; 5(1):1-24. PubMed ID: 15040375
[TBL] [Abstract][Full Text] [Related]
76. Is it ethical to give out unreadable information?
Hochhauser M
Manag Care Q; 2003; 11(2):33-6. PubMed ID: 12968442
[No Abstract] [Full Text] [Related]
77. Translational research in clinical trials: the only way forward.
Eggermont A; Newell H
Eur J Cancer; 2001 Nov; 37(16):1965. PubMed ID: 11699495
[No Abstract] [Full Text] [Related]
78. An investigational drug service at a pediatric hospital.
Mielke TR; Liptak CA; Summerfield M; Bertch JM
Top Hosp Pharm Manage; 1993 Apr; 13(1):47-54. PubMed ID: 10128792
[No Abstract] [Full Text] [Related]
79. Improvement of informed consent and the quality of consent documents.
Jefford M; Moore R
Lancet Oncol; 2008 May; 9(5):485-93. PubMed ID: 18452859
[TBL] [Abstract][Full Text] [Related]
80. Controversy trails adaptive clinical trials.
Goozner M
J Natl Cancer Inst; 2012 Sep; 104(18):1347-8. PubMed ID: 22984199
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
